Home › Calculator › KKPCF Dividend Calculator 2026
KKPCF DRIP Calculator & Dividend Yield 2026
4.79% YieldHealthcareKaken Pharmaceutical Co., Ltd. · OTC
Price: $26.00 · Annual div: $1.25/share · Frequency: semi-annual · Payout ratio: 2% · Ex-div: 2027-03-30
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When KKPCF pays your bills
Year your monthly dividend income covers each expense (based on current settings)
KKPCF Dividend History — Last 73 Payments
| Ex-Dividend Date | Payment Date | Amount / Share | TTM Yield | Stock Price |
|---|---|---|---|---|
| 2027-03-30Latest | 2027-03-30 | $0.6057 | — | — |
| 2026-09-30 | — | $0.6041 | 4.79% | $26.00 |
| 2026-03-31 | 2026-06-29 | $0.6414 | 4.94% | $26.00 |
| 2025-09-30 | 2025-11-28 | $0.6420 | 4.07% | $28.09 |
| 2025-03-31 | 2025-06-30 | $0.5003 | — | — |
| 2024-09-30 | 2024-11-29 | $0.8027 | 4.70% | $27.92 |
| 2024-03-28 | 2024-06-28 | $0.5088 | 6.37% | $23.95 |
| 2023-09-28 | 2023-11-30 | $0.5088 | 5.21% | $29.27 |
| 2023-03-30 | 2023-06-30 | $0.5088 | 3.79% | $26.85 |
| 2022-09-29 | 2022-11-30 | $0.5088 | 3.63% | $28.00 |
| 2022-03-30 | 2022-06-30 | $0.5088 | 2.55% | $39.84 |
| 2021-09-29 | 2021-11-30 | $0.5088 | 2.99% | $39.84 |
| 2021-03-30 | 2021-06-30 | $0.6806 | 3.78% | $36.80 |
| 2020-09-29 | 2020-11-30 | $0.7096 | — | — |
| 2020-03-30 | 2020-06-29 | $0.6939 | — | — |
| 2019-09-27 | 2019-11-29 | $0.6941 | — | — |
| 2019-03-27 | 2019-06-28 | $0.6794 | — | — |
| 2018-09-26 | 2018-11-30 | $0.6641 | — | — |
| 2018-03-28 | 2018-06-29 | $0.7056 | — | — |
| 2017-09-27 | 2017-11-30 | $0.6651 | — | — |
| 2017-03-29 | 2017-06-30 | $0.6753 | — | — |
| 2016-09-28 | 2016-11-30 | $0.7457 | — | — |
| 2016-03-29 | 2016-06-30 | $0.6882 | — | — |
| 2015-09-28 | 2015-11-30 | $0.5674 | — | — |
| 2015-03-27 | 2015-06-29 | $0.5372 | — | — |
| 2014-09-26 | 2014-11-28 | $0.4940 | — | — |
| 2014-03-27 | 2014-06-30 | $0.4700 | — | — |
| 2013-09-26 | 2013-12-03 | $0.4850 | — | — |
| 2013-03-27 | 2013-06-28 | $0.4662 | — | — |
| 2012-09-26 | 2012-12-04 | $0.5656 | — | — |
| 2012-03-28 | 2012-06-29 | $0.4834 | — | — |
| 2011-09-28 | 2011-12-02 | $0.5228 | — | — |
| 2011-03-29 | 2011-06-30 | $0.4370 | — | — |
| 2010-09-28 | 2010-12-02 | $0.4294 | — | — |
| 2010-03-29 | 2010-06-30 | $0.3238 | — | — |
| 2009-09-25 | 2009-12-03 | $0.3340 | — | — |
| 2009-03-26 | 2009-06-29 | $0.2630 | — | — |
| 2008-09-25 | 2008-12-04 | $0.2446 | — | — |
| 2008-03-26 | 2008-06-30 | $0.2020 | — | — |
| 2007-09-25 | 2007-12-06 | $0.1744 | — | — |
| 2007-03-27 | 2007-06-29 | $0.1440 | — | — |
| 2006-09-26 | 2006-12-06 | $0.1456 | — | — |
| 2006-03-28 | 2006-06-30 | $0.1284 | — | — |
| 2005-09-27 | 2005-12-08 | $0.1328 | — | — |
| 2005-03-28 | 2005-06-30 | $0.1122 | — | — |
| 2004-09-27 | 2004-12-09 | $0.1086 | — | — |
| 2004-03-26 | 2004-06-30 | $0.1036 | — | — |
| 2003-09-25 | 2003-12-09 | $0.0808 | — | — |
| 2003-03-26 | 2003-06-30 | $0.0750 | — | — |
| 2002-09-25 | 2002-12-10 | $0.0608 | — | — |
| 2002-03-26 | 2002-06-28 | $0.0562 | — | — |
| 2001-09-25 | 2001-12-10 | $0.0638 | — | — |
| 2001-03-27 | 2001-06-29 | $0.0612 | — | — |
| 2000-09-26 | 2000-12-05 | $0.0696 | — | — |
| 2000-03-28 | 2000-06-30 | $0.0702 | — | — |
| 1999-09-27 | 1999-12-03 | $7.5000 | — | — |
| 1999-03-26 | 1999-06-30 | $7.5000 | — | — |
| 1998-09-25 | 1998-12-04 | $7.5000 | — | — |
| 1998-03-26 | 1998-06-29 | $7.5000 | — | — |
| 1997-09-25 | 1997-12-05 | $7.5000 | — | — |
| 1997-03-26 | 1997-06-30 | $7.5000 | — | — |
| 1996-09-25 | 1996-12-06 | $7.5000 | — | — |
| 1996-03-26 | 1996-06-28 | $5.0000 | — | — |
| 1995-09-26 | 1995-12-06 | $10.0000 | — | — |
| 1995-03-28 | 1995-06-30 | $12.5000 | — | — |
| 1994-09-27 | 1994-12-06 | $7.5000 | — | — |
| 1994-03-28 | 1994-06-30 | $7.5000 | — | — |
| 1993-09-27 | 1993-12-07 | $7.5000 | — | — |
| 1993-03-26 | 1993-06-30 | $9.5238 | — | — |
| 1992-09-25 | 1992-12-08 | $4.7619 | — | — |
| 1992-03-26 | 1992-06-29 | $4.7619 | — | — |
| 1991-03-26 | 1991-06-28 | $9.5238 | — | — |
| 1990-03-27 | 1990-06-29 | $9.5238 | — | — |
About Kaken Pharmaceutical Co., Ltd. (KKPCF) — Dividend Analysis 2026
Kaken Pharmaceutical Co., Ltd., a Tokyo-based company established in 1917, operates globally, specializing in the development, manufacture, and commercialization of a diverse array of medical products, medical devices, and agrochemicals. Its comprehensive portfolio spans various therapeutic areas. Key pharmaceutical offerings include Clenafin, a topical solution for onychomycosis; Artz, an anti-osteoarthritis medication; Seprafilm, an absorbable adhesion barrier used on damaged tissue; Fiblast, a spray designed for treating pressure and other skin ulcers; Regroth, a product aiding periodontal regeneration; and Hernicore, used for lumbar disc herniation. Other notable pharmaceutical products include Adofeed and Loxoprofen Na Tape, both pain- and inflammation-relieving plasters; Ebrantil, addressing dysuria and hypertension; Procylin, an oral prostaglandin I2 analog; Lipidil, an anti-hyperlipidemia agent; Mentax, an anti-trichophyton agent; and Ropion, an injectable pain reliever. Beyond human medicine, Kaken supplies a range of agrochemicals and animal health solutions. These include Polyoxins, a fungicide; Pentoxazone, a herbicide for rice; and Salinomycin, an anti-coccidial feed additive for poultry. The company also maintains an active research and development pipeline. Promising candidates currently under development include BBI-4000, which has completed Phase III trials for primary axillary hyperhidrosis; KMW-1, also in Phase III for the removal of eschar from thermal burns; KAR, aimed at treating hide lice infestation; and KP-607, presently in Phase II for onychomycosis. Interestingly, its operations also extend to real estate, with involvement in the rental management of Bunkyo Green Court, a commercial complex. Its products are marketed under well-known brands such as Mentax Lotrimin Ultra, Mentax Butena, Mentax, Kaifen, Fiblast, and Jublia. Strategic partnerships include license agreements with Corbus Pharmaceuticals Holdings, Inc. and Arbor Pharmaceuticals, LLC.
Similar dividend stocks to KKPCF
Forward dividend yield from the latest data · open any DRIP calculator
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full KKPCF DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open KKPCF position with:
🌍 KKPCF Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold KKPCF.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 4.79% | 1.99% | $479 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 4.07% | 1.27% | $407 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 3.83% | 1.03% | $383 / yr |
| 🇬🇧 UK ISA | 0% | 4.79% | 1.99% | $479 / yr |
| 🇬🇧 UK Taxable | 8.75% | 4.37% | 1.57% | $437 / yr |
| 🇨🇦 TFSA | 0% | 4.79% | 1.99% | $479 / yr |
| 🇨🇦 CA Taxable | 25% | 3.59% | 0.79% | $359 / yr |
| 🇦🇺 Super (pension) | 15% | 4.07% | 1.27% | $407 / yr |
| 🇦🇺 AU Taxable | 30% | 3.35% | 0.55% | $335 / yr |
| 🇩🇪 DE Taxable | 26.375% | 3.53% | 0.73% | $353 / yr |
| 🇫🇷 FR Taxable | 30% | 3.35% | 0.55% | $335 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 KKPCF Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $1.25/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 KKPCF Dividend Payment Schedule
KKPCF pays quarterly — 4 times per year. Ex-div: 2027-03-30.
📊 KKPCF vs Healthcare Benchmarks
How KKPCF compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for KKPCF sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ KKPCF Insider Activity
No recent SEC filings reported in the last 90 days.Peer Group
Similar companies in the same sectorCompare KKPCF with peers: KKPCF vs AMPH · KKPCF vs AQST · KKPCF vs BIOGY
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the KKPCF dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Kaken Pharmaceutical Co., Ltd. (KKPCF) is currently trading at $26.00, 8% below its 52-week high. The current dividend yield is 4.79% based on an annual payout of $1.25 per share.
KKPCF (Kaken Pharmaceutical Co., Ltd.) — 4.79% Dividend Yield Analysis
Kaken Pharmaceutical Co., Ltd. (KKPCF) is a healthcare stock currently trading at $26.00 with a dividend yield of 4.79%. It pays an annual dividend of $1.25 per share. The payout ratio of 2% suggests the dividend is well-covered by earnings. Over the past 5 years, KKPCF has grown its dividend at a compound annual rate of 2.8%.
- Dividend payments are not guaranteed and can be reduced or suspended at any time.
Auto-generated from live market data. For educational purposes only — not financial advice.
Latest KKPCF News
LiveHow investors use the KKPCF dividend calculator
Illustrative examples of common use cases, written by the DividendFlow team — not customer reviews.